The United States announced that it will impose a 100% tariff on imported patented drugs and pharmaceutical ingredients.

The White House in the United States issued a statement on the 2nd, saying that President Trump signed a document on the same day, imposing a 100% tariff on imported patented drugs and pharmaceutical ingredients in accordance with Section 232 of the Trade Expansion Act of 1962. This measure also provides a pathway for exemptions or reduction of tariffs, with the aim of pressuring pharmaceutical companies to reach agreements with the White House on drug prices and industry reshoring.